Overactive IGF1/insulin receptors and NRASQ61R mutation drive mechanisms of resistance to pazopanib and define rational combination strategies to treat synovial sarcoma

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Overactive IGF1/insulin receptors and NRASQ61R mutation drive mechanisms of resistance to pazopanib and define rational combination strategies to treat synovial sarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences